There is provided herein the compositions and method for treating retinal disease. The composition and method include the therapeutic agent with vitreum component bound fraction conjugation. The vitreum component bound fraction can be the aptamer combined with the structural constituent of vitreous humor (for example, hyaluronic acid, collagen or vitronectin) or small molecule.